Doctors have reversed an inherited disorder in utero using a biotech drug

Doctors tried to lower $148K cancer drug cost; makers triple price of pill

FDA clears first contact lens with light-adaptive technology

The U.S. Food and Drug Administration today cleared the first contact lens to incorporate an additive that automatically darkens the lens when exposed to bright light. The Acuvue Oasys Contact Lenses with Transitions Light Intelligent Technology are soft contact lenses indicated for daily use to correct the vision of people with non-diseased eyes who are nearsighted (myopia) or farsighted (hyperopia). They can be used by people with certain degrees of astigmatism, an abnormal curvature of the eye.

Artificial antimicrobial peptides could help overcome drug-resistant bacteria

Researchers at MIT and the Catholic University of Brasilia have now developed a streamlined approach to developing artificial antimicrobial peptides. Their strategy, which relies on a computer algorithm that mimics the natural process of evolution, has yielded one potential drug candidate that successfully killed bacteria in mice.